| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |